LOX and tuberculosis: Clinical markers of TB disease severity and bacterial burden such as cavitary disease and number of days to Mtb positive culture (TTP) were both associated with levels of the LOX-derived metabolites LXA4, 12-HETE and 8-HETE in plasma.